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Summary The histological detection of tumour metastases in axillary lymph nodes from cases of breast
carcinoma is of major prognostic significance, but may be difficult when metastases are of microscopic size.
We have therefore investigated whether immunohistological techniques can increase the accuracy of metastasis
detection in axillary lymph nodes. Forty-five cases of breast carcinoma were studied, in all of whom the
axillary lymph nodes had been reported as free of metastases. Paraffin sections from these cases were stained
by immunoenzymatic techniques, using monoclonal antibodies directed against human milk fat globule
membrane antigen ("anti-EMA") and against epithelial intermediate filaments ("anti-keratin"). In 4/12 cases
of lobular carcinoma and in 3/33 cases of ductal carcinoma, previously unsuspected micrometastases were
revealed by immunohistological staining, representing an overall increase in detection rate of 15% (and of
33% for the lobular carcinoma cases). In addition to this group of 45 histologically "negative" biopsies, 12
samples were studied in which only a proportion of the nodes had been reported as containing tumour. In 5
of these cases immunostaining revealed previously undetected metastases. These findings suggest that
immunohistological analysis may have a routine role to play in the staging of breast carcinoma. It is noted
that the 15% increase in diagnostic accuracy achieved in the present study is comparable to the proportion of
breast carcinoma patients in whom disseminated disease develops despite their axillary lymph nodes being
reported as tumour-free at the time of surgery.
It is now widely accepted that involvement of
axillary lymph nodes by breast cancer has an
important bearing on prognosis (Breast Cancer
Study Group, 1978; Elston et al., 1982) and a
decision on whether or not to undertake adjuvant
chemotherapy frequently hinges on the number of
involved nodes (Bonadonna, 1980). However, use
of this criterion presupposes that micrometastases
can reliably be detected by conventional histological
procedures, e.g.: by examination of haematoxylin/
eosin or mucin stains. A negative report therefore
indicates that the histopathologist has been unable
to identify any malignant cells, rather than that
they are absent.
One potential means of improving observer
accuracy in the detection of axillary
micrometastases is to use immunocytochemical
techniques. It has recently been reported by
Redding et al. (1983) that small numbers of
malignant cells may be detected by this approach in
bone marrow samples from cases of human
carcinoma when skeletal involvement is not evident
from any other criteria. We have also recently
reported that otherwise undetectable neoplastic cells
can be demonstrated by immunocytochemical
labelling in approximately 30% of cytologically
"6negative" serous effusions from cancer patients
(Ghosh et al., 1983).
We therefore undertook in the present study to
assess whether immunocytological examination of
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axillary lymph nodes would offer any advantage
over conventional histopathology in the detection
of micrometastases.
Tissues
All sections tested were prepared from routine
formalin fixed paraffin embedded samples from the
files of the Pathology Department of the John
Radcliffe Hospital, Oxford. The specimens
consisted of axillary lymph nodes removed at the
time of surgery for breast carcinoma. The samples
studied represented a random selection of
mastectomy specimens received in the Department
since 1980 in which axillary lymph nodes had been
reported histologically as uninvolved by tumour, or
in which only a proportion of the nodes were
involved.
In Oxford there is no uniform surgical policy for
sampling axillary lymph nodes. In this study, the
average number of lymph nodes examined per case
was 4, with the total number ranging from 1 to 11.
Routine histological examination usually consists
only of examination of one haematoxylin and eosin
stained section per lymph node. Special stains such
as Alcian blue-PAS had been performed originally
only on a minority of cases in this study.
Monoclonal antibodies
Three monoclonal antibodies were used in this
investigation. Two were directed against human
milk fat globule membrane antigens. One of these
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(E29) was raised in our own laboratory (Gatter et
al., 1984), whilst the other (HMFG2) was produced
in the ICRF Laboratories, London (Taylor-
Papadimitriou et al., 1981) and is obtainable from
Seward Laboratory. Both antibodies were used as
tissue culture supernatant diluted 1:10. The third
antibody (KLl), kindly provided by Dr. J.
Brochier, was raised against cytokeratins extracted
from human epidermis. This antibody consisted of
a purified immunoglobulin fraction and was diluted
1:100. The two anti-milk fat globule membrane
antibodies have been screened in this laboratory in
the past on normal and malignant tissues both in
cryostat and paraffin embedded material (Arklie et
al., 1981; Gatter et al., 1982, 1984). Antibody KLl
has been tested in its laboratory of origin on
human tissues and found to stain most human
epithelia but not non-epithelial cells or tissues.
Immunoenzymatic reagents
Peroxidase-conjugated rabbit antibodies to mouse
Ig and swine antibodies to rabbit Ig were obtained
from Dakopatts a/s. Alkaline phosphatase-
conjugated anti-mouse Ig was kindly provided
by Dr. K.-J. Pluzek. Diaminobenzidine
tetrahydrochloride was obtained from Sigma
Chemical Company. Tris buffered saline (TBS) was
prepared by adding a tenth volume of
0.5 MTrisHCl buffer (pH 7.6) to 0.15M saline.
Immunoperoxidase staining
Sections were prepared for staining by dewaxing
and washing in TBS. Dewaxed sections were then
incubated with monoclonal antibody for 30min in
a covered chamber. Sections were washed briefly in
TBS and incubated for a further 30min with
peroxidase-conjugated rabbit anti-mouse Ig, diluted
1:50 in TBS to (which normal human serum has
been added, at a final concentration of 1: 2, in
order to block cross-reactivity against human Ig).
After washing in TBS, sections were incubated for
a further 30min with peroxidase-conjugated swine
anti-rabbit Ig diluted 1:100 in TBS (containing
normal human serum at a final concentration of
1:2).
Sections were then washed in TBS and the
peroxidase reaction developed by incubating
sections with TBS containing diaminobenzidine
(0.6mgml-1) and H202 (0.01%) for 5-10min at
room temperature. Sections were washed in tap
water, counterstained with haematoxylin and
mounted for microscopical examination.
Immuno-alkaline phosphatase labelling
Some of the sections investigated in this study were
analysed by a two-stage indirect immuno-alkaline
phosphatase procedure. In this technique the initial
stages up to and including incubation with the
monoclonal antibody were performed as described
above. Sections were then washed and incubated
with alkaline phosphatase-conjugated rabbit anti-
mouse Ig, diluted 1:20 in TBS containing 5%
normal human serum. After a further wash the
alkaline phosphatase reaction was developed using
a substrate containing hexazotised new fuchsin and
naphthol AS-MX, as described previously (Cordell
et al., 1984).
Results
The results of this study are considered under two
heads: firstly those cases in which no evidence of
involvement by malignant cells was detected on
routine histological examination in any of the nodes
examined; and, secondly, those cases in which a
proportion but not all of the nodes examined had
been reported as containing metastatic carcinoma.
Histologically negative nodes
Axillary nodes from 45 cases of breast cancer
(comprising 12 cases of lobular carcinoma and 33
of ductal carcinoma) which had previously been
reported as ininvolved by tumour was examined
immunocytochemically.
In 4 cases of lobular (33%) and 3 cases of ductal
(9%) carcinoma micrometastases were revealed by
histological staining.
Figures 1-6 illustrate the typical appearance of
the immunocytochemical labelling reactions. It was
noted that in most cases the tumour cells were
present as single cells or small cell clusters in the
sub-capsular or medullary sinuses (Figures 1-3)
although in a few nodes widely disseminated (and
previously unsuspected) neoplastic involvement
throughout the substance of the node was revealed
by immunohistological staining (Figures 5 and 6).
No differences were seen in the distribution of
occult tumour cells between lobular and ductal
carcinomas.
H and E and Alcian blue-PAS stained adjacent
sections from all cases in which immunohistological
staining revealed the presence of previously
undetected metastases were re-examined. It was
possible to identify the malignant cells in most
sections stained in this way, since the
immunohistological labelling indicated precisely
where they should be sought. However it should be
emphasised that in most cases the number of
carcinoma cells was low, and it was consequently
only with the benefit of hindsight that neoplastic
cells could be identified by H and E and Alcian
blue-PAS staining.MICROMETASTASIS IN BREAST CANCER 195
Figure 1 Immuno-peroxidase staining of a paraffin
embedded axillary lymph node with monoclonal
antibody E29 (anti-human milk fat globule membrane
antigen). The biopsy had been reported on
conventional histological examination as being free of
tumour. However a strongly stained micrometastatic
deposit is seen in the sub-capsular sinus (arrow).
Figure 2 Haematoxylin and eosin stained section
adjacent to that illustrated in Figure 1. The deposit of
neoplastic cells in the sub-capsular sinus could be
identified (arrow) by careful examination of the area in
which the immunoperoxidase labelled cells had been
seen.
Figure 3 Immunoperoxidase detection of single
neoplastic cells (arrows) in a sinus from an axillary
lymph node which had been reported histologically as
free of tumour. (Antibody E29).
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Figure 4 Low power photomicrpgraph of a
haematoxylin and eosin stained axillary lymph node
section in which metastases could not be detected,
even on subsequent review, by a number of
histopathologists.
Figure 5 An adjacent section to Figure 4 stained by
the immuno-alkaline phosphatase method with the
anti-keratin antibody KL1. It can clearly be seen at
low power that there are a large number of infiltrating
carcinoma cells present not only in the thickened
capsule but also within the substance of the lymph
node itself.
Figure 6 A high power field from the case illustrated
in Figure 4 stained for milk fat globule membrane
antigen (antibody E29) using an immunoperoxidase
technique. The neoplastic cells are characterised by the
presence of intracytoplasmic lumina (arrows). These
structures could be identified in Alcian blue-PAS
stained sections (although only when the sites of
neoplastic cell infiltration had been identified by
immunohistological labelling).196 C.A. WELLS et al.
Indeed the case illustrated in Figures 4-6, which
actually contained a considerable number of
carcinoma cells, was submitted blind during the
course of this study to a meeting of
histopathologists, none of whom identified the
metastatic cells.
Each of the three monoclonal antibodies gave
approximately equal intensity and distribution of
staining.
Metastases reported in some, but not all, nodes
This group comprised 12 specimens in which
carcinoma had been found on conventional
histological examination in a proportion of the
nodes (3 or less). In 5 of these cases immuno-
histological staining revealed involvement in a
higher percentage of nodes than had previously
been recognised. Three of these cases were examples
of lobular carcinoma and two of ductal carcinoma.
In all cases the metastatic deposits which had been
recognised on conventional histology were strongly
stained by the 3 monoclonal antibodies.
Discussion
This study has shown that in 12/57 cases of breast
cancer it was possible to detect axillary lymph node
metastatases which had been undetected previously
on conventional histological examination (including
mucin staining). This represents an increase in
diagnostic accuracy ofjust over 20%.
Among 45 cases in which the lymph nodes had
been reported previously as being free of tumour, 7
cases could be shown to contain micrometastases in
one or more lymph nodes. Since 4 of these
micrometastases were detected amongst the 12 cases
(33%) of lobular carcinoma, with only 3 cases
being seen in the 33 (9%) ductal carcinomas, the
former group may be the most profitable to
examine in a larger study.
In the remaining 12 cases metastatic deposits had
already been identified on routine histological
examination of a proportion of the lymph nodes
received. However immunohistological labelling
enabled additional involved nodes to be identified
in five cases: this is of potential clinical significance
in the context of chemotherapy trials in which
treatment is dependent upon the number of
involved lymph nodes (Bonadonna, 1980).
The results in this paper should be compared
with those previously reported by Sloane et al.
(1980) in which lymph nodes from cases of breast
cancer were examined immunohistologically using a
polyclonal antiserum directed against epithelial
membrane antigen (similar in its specificity to the
two monoclonal anti-milk fat globule membrane
antigen antibodies used in the present study).
However Sloane et al. (1980) found it impossible by
immunohistological labelling to reveal metastases
which had not been observed on conventional
histopathological examination. The explanation of
the discrepancy between the results of Sloane et al.
and those reported here is not immediately obvious.
It is conceivable that it reflects the greater
diagnostic accuracy of the histopathologists who
initially examined the lymph nodes studied by
Sloane et al. (1980). However the cases included in
the present series had all been reported by
experienced histopathologists, so that this
explanation seems unlikely. It seems more probable
that the use of monoclonal antibodies, which are
inherently of higher specificity and tend to give
cleaner and more clear-cut positive reactions than
polyclonal reagents, and also the fact that staining
was performed by sensitive immunoenzymatic
procedures, accounts for the difference between the
results of the two studies.
Throughout this study, in view of the interest
generated in the department, many of the cases
were reviewed blind by other histopathologists. In
spite of being alerted to the challenge of finding
unsuspected micrometastases they were unable to
identify most of the carcinoma cells but often
questioned the status of innocent macrophages or
lymphoid cells. One objection to this study is that
the sampling rate at the time of original diagnosis
(one haematoxylin and eosin stain per lymph node)
was too low. In this study of 45 cases serial sections
were taken for immunostaining, often cutting the
blocks to extinction. In a few cases the carcinoma
cells became more obvious and thus potentially
identifiable at the time of original diagnosis. In
other cases the reverse was true, i.e. that review of
the area picked out by immunostaining showed
more carcinoma cells in the original diagnostic
slides. Although experienced histopathologists,
given adequate time and a large number of sections,
might pick up many of these cases the important
point to emphasize is the ease and confidence with
which these micrometastases can be identified by
immunostaining. The techniques are straight-
forward and suitable for the diagnostic laboratory.
The monoclonal antibodies are, or soon will be,
available at reasonable cost.
It is of interest to consider the practical clinical
importance of the findings reported in the present
paper, since, if the detection of micrometastases
influences prognosis and patient management, there
is clearly a strong argument for introducing this
procedure as part of the routine process of
histopathological examination of axillary lymph
nodes. Early studies concluded that the prognosis in
breast cancer is not influenced by the presence of
micrometastases in local lymph nodes (Huvos et al.,MICROMETASTASIS IN BREAST CANCER 197
1971; Attiyeh et al., 1977; Fisher et al., 1978).
However a recent study from the Sloan-Kettering
Cancer Center, New York, of patients with a single
lymph node metastasis (Rosen et al., 1981) has
shown that, although micrometastases are of no
clinical significance six years after surgery, the
survival of these patients is nearly identical to that
of patients with macrometastases when results are
analysed after twelve years.
Of further relevance to the present report is the
fact that approximately 20% of breast cancer
patients in the Sloan-Kettering series, in whom
axillary lymph nodes had been reported as free
from tumour, subsequently developed clinical
evidence of metastases. This figure is comparable to
the percentage of patients in the present series
(7/45-15%) in whom micrometastases were
detected by immunohistological labelling. The
recent report (Redding et al., 1983) that bone
marrow micrometastases could be detected by
immunocytochemical means in 24% of a series of
54 breast cancer patients with histologically
negative lymph nodes may also be pertinent in this
context. It is clearly of importance to establish, by
studying a larger group of patients over a period of
time, whether or not the detection of
micrometastases in patients who have apparently
normal lymph nodes on histological examination
does indeed indicate a poorer prognosis, and to
determine what relationship this bears to bone
marrow micrometastases.
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